Vertex Pharmaceuticals has received a “Moderate Buy” consensus from 29 brokerages, with most analysts either holding or ...

In an era of rising complexity, rapid technology shifts, budget pressures, and uninsurable risks, traditional security approaches no longer suffice. Businesses need to understand where they're ...